• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » BIO-clusters Lyonbiopole, Alsace BioValley, CQDM to foster R&D

BIO-clusters Lyonbiopole, Alsace BioValley, CQDM to foster R&D

June 21, 2012
CenterWatch Staff

Lyonbiopole, a French competitiveness cluster of 110 members focused on infectious diseases and cancers, has joined the existing consortium between Alsace BioValley, a French competitiveness cluster dedicated to life sciences and health, and Quebec Consortium for Drug Discovery (CQDM).

A first agreement, signed in November 2010 between the two partners had already helped to initiate several research collaboration between actors in Alsace and Quebec. With these early successes and the special relationship established between Alsace BioValley and Lyonbiopole, a new bilateral agreement has been recently signed between CQDM and Lyonbiopole.

"Our partnership with Alsace BioValley has been successful with, to date, funding for three joint research projects, with high quality and high impact on the biopharmaceutical industry," said Diane Gosselin, vice president of research and business development, CQDM. "We are very pleased to expand the cooperation in the Rhone-Alpes region with Lyonbiopole whose excellence and competitiveness in several areas of research is recognized worldwide."

This new agreement aims to develop a joint program to enhance biomedical research in Quebec, Canada, and  Alsace and Rhone-Alpes, France, by the alignment of international resources. The trio will co-finance research projects aimed at developing new technologies or enablers for biopharmaceutical research, conducted in collaboration between the three regions. Promoting creativity, innovation and multidisciplinary collaboration between academic institutions and private organizations (biotech/research organizations under contract CRO), the tripartite call for project will allocate a maximum funding of $1.4 million for a three-year period.

Scientific excellence, applicability and feasibility of the project will be evaluated by external evaluators, selected jointly by the three parties. Particular attention will be paid to the ability to produce applicable results (after funding period), having an immediate impact for biopharmaceutical research. CQDM, Alsace BioValley and Lyonbiopole will evaluate aspects related to intellectual property, potential ethical issues, corporate information as well as any potential risks that could endanger the achievement of a research project.

    Upcoming Events

    • 16Oct

      MAGI@home Clinical Research Conference 2023

    • 25Oct

      2023 WCG Patient Forum

    • 26Oct

      FDA in 2024: What to Expect in an Election Year

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Donna Snyder

      New WCG Executive Physician Outlines Goals for Clinical Research

    • Hand Shake at Meeting

      Partnership to Bolster Trials in Low Resource Regions Kicks Off

    • Guidelines-360x240.png

      Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

    • AsktheExpertsBadge-360x240.png

      Ask the Experts: Monitoring

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing